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The public health impact of fetal alcohol spectrum 
disorders is underestimated
Fetal  alcohol  spectrum  disorders  (FASD)  are  charac­
terized by a continuum of structural and neuro  develop­
mental anomalies following a history of in utero alcohol 
exposure.  Clinical  diagnostic  guidelines  have  been 
developed to aid accurate diagnosis [1­3] and to differ­
entiate between fetal alcohol syndrome (FAS) at the most 
severe  end  of  the  spectrum,  and  partial  fetal  alcohol 
syndrome,  alcohol­related  birth  defects  and  alcohol­
related neurodevelopmental disorder. FAS manifests with 
a set of characteristics, including craniofacial dys  morph­
ology  (such  as  a  thin  upper  lip,  smooth  philtrum  and 
small eye openings), pre­ and postnatal growth retarda­
tion,  and  abnormal  growth  and  development  of  the 
central  nervous  system,  resulting  in  lifelong  mental, 
cognitive and behavioral disabilities. FASD is the com­
mon  est preventable cause of mental disability. In most 
countries the prevalence of FAS ranges between 0.5 and 
2.0 per 1,000 live births [4], but it is strikingly higher in 
some communities. In South Africa, a prevalence as high 
as  65.2  per  1,000  children  of  school­going  age  was 
reported in a mixed ancestry community in the Western 
Cape [5] and 67.2 per 1,000 children in similar commu­
nities in the Northern Cape Province [6].
The global burden of alcohol­related disease accounted 
for 4% of all disability­adjusted life years as reported in 
2004, with striking regional differences [7], up from 3.5% 
in 1990. Although it is estimated that only between 5% 
and 10% of offspring exposed in utero are likely to have 
alcohol­related  deficits  [8],  this  is  probably  an  under­
estimate [9]. It is possible that many idiopathic neuro­
developmental disorders, including some cases of autism 
and attention deficit hyperactivity disorder (ADHD), may 
also be attributable to transgenerational effects of alcohol 
exposure.  In  the  USA,  it  is  estimated  that  FASD  may 
affect  up  to  1%  of  the  population  [10]  and  incur  con­
siderable  costs  [11],  but  the  prevalence,  especially  in 
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higher than reported estimates [12,13].
Lessons from early studies in humans and in 
animal models
The deleterious effects of parental alcohol use on their 
offspring  have  been  recognized  and  documented  for 
centuries, including observations during the ‘gin epidemic’ 
in England (1720 to 1750) and reports during the 19th and 
early 20th centuries (summarized by Warner and Rosett 
[14]).  The  term  fetal  alcohol  syndrome  (FAS)  and  the 
formal medical description is as recent as 1973 [15].
Many animal studies have shown that clinical severity 
following in utero ethanol exposure correlates with the 
developmental stage (timing), the dose and the frequency 
of exposure (chronic versus acute) [16,17]; it is the result 
of complex gene­environment interactions that alter gene 
expression patterns, especially during development. The 
first trimester is considered the most vulnerable period, 
but  fetal  damage  occurs  throughout  gestation.  Rodent 
models have been used most often (especially the mouse 
and rat) and various regimens of alcohol administration 
have resulted in remarkable phenotypic similarities with 
the  features  of  FASD  in  humans,  including  distinctive 
craniofacial  alterations,  stunted  growth  and  behavioral 
abnormalities.  What  has  become  clear,  however,  as 
demonstrated by crosses between inbred mouse strains 
that were similarly exposed to alcohol, is that the parental 
genomic  contributions  to  the  fetus  are  important  in 
attributing risk.
The role of genetic variation in FASD remains 
poorly understood
There is no question that genetic variation has a role in 
susceptibility to adverse effects following in utero alcohol 
exposure. The question is, therefore, what is the nature 
and magnitude of the genetic effect and how does genetic 
variation interact with environmental factors (for example, 
nutrition  and  environmentally  induced  epigenetic 
remodeling) to cause teratogenic effects. Many studies in 
rodent models have indicated that genetic background is 
crucial  in  understanding  risk,  as  there  are  recognized 
susceptible inbred mouse strains and other inbred strains 
that  remain  unaffected  despite  similar  exposure  to 
ethanol [18­20]. Differences among these strains relate to 
alcohol preference, alcohol metabolism and behavior. For 
example,  mouse  studies  demonstrated  an  inverse 
relationship  between  maternal  alcohol  dehydrogenase 
activity and maternal blood alcohol levels and consequent 
fetal  abnormalities,  but  suggested  that  other  inherited 
factors  from  both  the  mother  and  the  fetus  were  also 
important [19,21­23].
In contrast, relatively few studies have investigated the 
role  of  genetic  variation  in  humans  in  determining 
predisposition and clinical severity. It has, however, been 
documented  that  siblings  of  FAS  children  have  a 
dramatically increased risk for FAS (170 per 1,000 among 
older sibs and 771 per 1,000 in younger sibs compared 
with 1.9 per 1,000 in the population studied as a whole) 
and there is higher concordance between monozygotic 
twins  than  between  dizygotic  twins  [24,25].  Genetic 
studies have primarily explored the role of alcohol­meta­
bo  lizing  enzymes,  including  alcohol  dehydrogenases 
(ADH),  aldehyde  dehydrogenases  (ALDH)  and  cyto­
chrome  P450  2E1  (CYP2E1),  in  the  mothers  and  their 
FAS  offspring;  these  studies  have  used  relatively  small 
sample  sizes  [26,27].  Functionally  significant  non­
synony  mous variants at the ADH1B locus (ADH1B*2 and 
ADH1B*3),  which  result  in  faster  and  more  efficient 
ethanol  clearance,  have  been  associated  with  a  mild 
protective  effect  in  case­control  and  cohort  studies  in 
several populations, including African Americans [28,29] 
and South Africans of mixed ancestry [30], although in 
association with different alleles [26,27,31]. The mode of 
action is unclear but a recent study in a large European 
population  demonstrated  a  strong  association  between 
one  of  these  ADH1B  non­synonymous  variant  alleles 
(ADH1B*2; rs1229984) and lower alcohol consumption 
before  and  during  pregnancy  [32].  Excessive  alcohol 
exposure can induce CYP2E1 expression, another route 
for alcohol metabolism. Some CYP2E1 allelic variants are 
associated  with  enhanced  metabolic  capacity  and  may 
modulate  the  risk  for  FAS.  Furthermore,  CYP2E1  is 
expressed  in  the  placenta,  fetal  liver  and  fetal  brain 
during  organogenesis,  where  the  CYP2E1­catalyzed 
oxidation of ethanol may cause oxidative stress (reviewed 
in  Gemma  et  al.  [27]).  No  genome­wide  association 
studies  have  been  done  for  FAS  or  FASD,  probably 
because of the recognition of multiple common environ­
mental  risk  factors  that  are  difficult  to  quantify  and  a 
paucity of large sample sizes and appropriate controls.
The impact of alcohol on biological pathways and 
the mechanisms of teratogenesis
Efforts to understand the effects of alcohol exposure on 
the adult and developing brain, as well as other physio­
logical impacts, have led to a vast literature describing 
the  effects  of  alcohol  on  cells,  organs  and  organisms 
(reviewed in [33­35]). Genetic contributions to pre  dispo­
sition  have  been  explored  to  a  limited  extent,  but 
important  insight  has  come  from  investigating  gene 
expression,  biochemical  markers  and  physiological 
effects of pre­ and postnatal alcohol exposure. These are 
mediated through pathogenic mechanisms that involve 
many pathways that have been extensively studied in the 
liver (the main site of ethanol metabolism and its toxic 
metabolites,  including  acetaldehyde)  and  the  nervous 
system (including the brain). The origins and mechanisms 
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have been examined and compounds that exacerbate or 
ameliorate the teratogenic effects of alcohol have been 
shown to include antioxidants, sonic hedgehog protein 
and retinoids (summarized by Sulik [36]).
Common functional deficits following in utero alcohol 
exposure in mouse and rat models include cell prolifera­
tion,  differentiation  and  apoptosis,  affecting  tissue 
growth and remodeling and specifically neuronal growth 
and survival. Preliminary global gene expression studies 
have  corroborated  some  of  these  findings  and  have 
revealed  the  involvement  of  groups  of  genes  related 
through  function  or  common  pathways.  Each  experi­
mental  design  was  different,  making  it  difficult  to 
compare the studies, but the main conclusions are sum­
marized in Table 1 [37­41].
Bioinformatic analyses of gene expression microarray 
data from fetuses exposed and unexposed to alcohol have 
examined  upstream  regulatory  regions  for  common 
transcription binding sites and 5’ untranslated regions for 
potential  microRNA  (miRNA)  binding  sites  for 
differentially  expressed  genes.  The  results  suggest  that 
alterations  in  miRNA  functions  may  have  a  role  in 
alcohol­related  teratogenicity  [41].  In  addition,  fetal 
alcohol exposure was shown to alter common signaling 
pathways  linking  receptor  activation  to  cytoskeletal 
reorganization, causing altered cell motility and mobility 
as well as metabolic capacity [40]. More focused rodent 
gene  expression  studies  have  explored  central  nervous 
system  development  and  neuronal  migration,  gluco­
corticoid signaling, and nitric oxide, insulin and retinol 
levels following in utero alcohol exposure (for example, 
[42­44]).
Gene  expression  is  known  to  be  altered  by  DNA 
methylation  status  and  by  chromatin  remodeling 
following  histone  modification,  including  methylation, 
acetylation  and  phosphorylation.  Given  that  abnormal 
neuronal development and neurodegeneration are charac­
teristics  of  FASD  and  alcoholism,  it  is  important  to 
understand how these molecular processes are altered in 
affected tissues. Particular emphasis has been placed on 
understanding the effect of alcohol on the methyl donor 
pathway,  including  S­adenosylmethionine  (a  methyl 
donor) and the DNA methyltransferases [45,46]. One of 
the  early  studies  demonstrated  that  acute  alcohol 
exposure in pregnant mice (from gestation day 9 to 11) 
resulted in reduced methylation of fetal DNA and levels 
of DNA methyltransferase [47]. Another study in male 
rats  showed  significantly  decreased  cytosine  methyl­
transferase  (Dnmt1)  mRNA  levels  in  their  sperm, 
suggest  ing  that  this  may  be  one  of  the  mechanisms 
leading to altered gene expression levels after conception 
[48]. Ethanol has also been demonstrated to be associated 
with  post­translational  histone  modification  in  a  rat 
model [49­51]. Significant changes in DNA methylation 
were observed during early embryonic development of 
the nervous system involving genes known to have a role 
in the cell cycle, growth and apoptosis, with increased 
Table 1. Global gene expression studies after in utero alcohol exposure in mouse models
    Key upregulated  Key downregulated  Functional    
Alcohol exposure*  Tissue  genes/pathways  genes/pathways  pathway  References
GD7-9   Fetal brain    Timp4, Bmp15, Rnf25, Tulp4 and  Cell proliferation, cell  [37]
(daily intraperitoneal       Dexras1  differentiation and apoptosis; 
dose 2.9 g/kg)         affecting tissue growth and  
        remodeling and neural growth  
        and survival
GD8   Head fold, 3 h  B6N†: glycolysis and  B6N†: ribosomal proteins  Common signaling pathways  [40]
(2 doses, 4 h apart,   after alcohol   pentose phosphate  and proteasome; B6J†: none  linking receptor activation to 
2.9 g/kg)  exposure   pathway; B6J† and B6N†:   detected  cytoskeletal reorganization 
    tight junction, focal  
    adhesion, adherens junction  
    and regulation of the  
    actin cytoskeleton
GD8.25   Whole embryo  All 3’ miRNA motifs  Most 5’ cis-acting regulatory  Developmental deficit of   [41]
for 46 h (peak   culture  showed upregulatory  motifs (transcription binding  growth, neuronal axis and    
alcohol concentration    effects‡  sites) showed down regulatory   neural patterning,  
88 mM)      effects  hemopoiesis and apoptosis 
GD8.25   Whole embryo  Decreased methylation:   Increased methylation:   Metabolism (Cyp4f13);   [38]
for 46 h (peak   culture  Nlgn3, Elavl2, Sox 21, Sim1,   Cyp4f13  imprinting (Igf2r); chromatin 
alcohol concentration    Igf2r and Histh3d    (Histh3d); and development 
88 mM)        (other genes)  
GD0.5-8.5   Liver from   D14ertd449e, Ly6e  Lima1, Socs2, Cables1  Growth; nervous system  [39]
  28-day-old males  and Rrm2  and Vidir  development 
*GD, gestational day. †C57BL/6 substrains: B6J embryos had a higher incidence of FASD features than B6N. ‡A possible interpretation is that many highly expressed 
genes were not appropriately downregulated because of delayed expression of miRNAs that would normally reduce expression.
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others [38].
Epigenetic remodeling and vulnerability to the 
teratogenic effects of alcohol: preconception, early 
development and transgenerational effects
In 1920 Lord D’Abernon set the scene by writing in the 
preface to the second edition of Alcohol: Its Action on the 
Organism  [52]  a  list  of  research  questions  that  should 
receive  priority,  including:  ‘Does  parental  alcoholism 
affect  injuriously  the  health  and  development  of  off­
spring,  and  if  so,  are  the  resultant  conditions  trans­
missible to subsequent generations?’
The previous section provided some evidence support­
ing the involvement of epigenetic remodeling in alcohol 
teratogenesis, and this hypothesis is further summarized 
in a recent review supporting an epigenetic dimension as 
one  of  the  key  molecular  mechanisms  in  FASD  [53]. 
During  development  there  are  essentially  three  main 
stages of generalized global epigenetic remodeling: first, 
during gametogenesis, when there is a wave of demethyl­
ation  followed  by  sex­specific  genetic  imprinting  and 
generalized methylation; second, during preimplantation, 
which  is  characterized  by  generalized  DNA  demethyl­
ation in the zygote (with the exception of imprinted loci); 
and third, another wave of de novo methylation during 
gastrulation [54]. Each of these stages therefore charac­
terizes a time of particular vulnerability for the disruption 
of normal epigenetic signals and the adverse effects of 
alcohol exposure. There is ample evidence to suggest that 
epigenetic perturbations are subtle and not all­or­nothing 
responses,  resulting  in  shifts  towards  increased  or 
decreased gene expression, a phenomenon that would be 
in  line  with  the  broad  range  of  clinical  manifestations 
reflecting a dynamic and individual response to alcohol 
exposure.
The  consequences  of  epigenetic  remodeling  can  be 
studied at a genomic level [55] but to thoroughly explore 
cause  and  effect  would  require  additional  biochemical 
and proteomic studies to understand the complex, inter­
related  molecular  underpinnings  of  alcohol  effects  in 
FASD. Several reviews have documented the teratogenic 
effects  of  alcohol  in  animal  models  [56,57].  Below  I 
summarize  current  knowledge  regarding  the  effects  of 
alcohol  exposure  from  the  preconception  stage  to 
preimplantation and gastrulation on fetal and postnatal 
development. The evidence for transgenerational effects 
of environmental alcohol exposure is briefly summarized.
Despite an emphasis on maternal alcohol consumption 
as  the  major  driver  of  fetal  alcohol  effects,  the  role  of 
alcohol in the preconception period in men and its effect 
on  their  offspring,  even  in  the  absence  of  gestational 
alcohol  exposure,  has  long  been  recognized  [58].  The 
deleterious  effects  of  paternal  preconception  alcohol 
exposure  have  now  been  well  documented  in  humans 
and include reduced birth weight and impaired cognitive 
functioning  [59,60];  however,  the  mechanisms  remain 
poorly  understood.  In  an  attempt  to  establish  a  link 
between  alcohol  consumption  in  men  and  epigenetic 
changes in sperm DNA, paternally imprinted loci were 
examined  and  compared  between  different  alcohol­
consuming  groups.  In  a  modest  study  [61],  a  trend 
toward  CpG  hypomethylation  in  moderate  to  heavy 
drinkers was observed and reached statistical significance 
for one differentially methylated region (DMR), but not 
for another. The effects of alcohol on sperm DNA methyl­
ation  need  further  exploration,  as  do  other  epigenetic 
mechanisms,  including  histone  modification  and  the 
transmission of RNA species that may affect gene expres­
sion in the gametes and early zygote.
It is not surprising that there have been a variety of 
outcomes  in  rodent  studies  exploring  paternal  precon­
ception  effects,  as  the  experimental  approaches  have 
differed in design, including dosage (chronic or acute, the 
latter mimicking binge drinking behavior), administration 
regime (inhalation, intraperitoneal injection and gavage) 
and the length of exposure. However, and some excep­
tions  aside,  a  definite  trend  is  evident  with  increasing 
exposure  that  reflects  reduced  birth  weight  in  the 
offspring  [62­64],  fewer  offspring  [64,65],  and  an 
increased  number  of  malformations  [64,66],  including 
dysmorphic  craniofacial  features  and  behavioral  or 
cognitive effects [67­70].
Preconception effects in women are more difficult to 
study  as  they  are  invariably  influenced  by  alcoholic 
behavior that persists into pregnancy and by malnutrition 
and socioeconomic status [53,71]. The effect on female 
mice exposed chronically for 10 weeks before conception, 
but not during pregnancy, showed increased transcrip­
tional silencing of the agouti yellow viable allele (Avy) in 
the offspring, in a similar trend to those exposed during 
pregnancy  [39].  These  effects  are  indirect  because  the 
transcriptional signaling comes from altered methylation 
of  the  Avy  allele,  which  was  paternally  derived  in  this 
experimental model. In earlier mouse studies, fetuses and 
offspring of females exposed only in the preconception 
period had significantly retarded growth [72­74].
In  humans  the  preimplantation  period  relates  to  the 
first 2 weeks following fertilization, and in mice up to the 
first  6  days;  this  is  followed  by  implantation  and 
gastrulation, which is characterized by the formation of 
the three primary germ layers (mesoderm, ectoderm and 
endoderm). Some studies have particularly addressed the 
effects  of  alcohol  during  these  early  stages  and  have 
demonstrated that it produces adverse outcomes on the 
placenta,  the  fetus,  newborn  and  adult  [75,76].  An 
imprinting mechanism was explored in two recent mouse 
studies.  Preimplantation  ethanol  exposure  resulted  in 
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decreased DNA methylation of the paternal allele of the 
H19  imprinting  control  region  of  the  placenta  of 
midgestation embryos, but not the embryos themselves 
[77]. Using the Avy allele as a reporter gene, gestational 
exposure during days 1 to 8 after fertilization was shown 
to result in a significant shift to an increased proportion 
of  pseudoagouti  offspring  mediated  through  transcrip­
tional  silencing  of  the  agouti  locus  [39].  Both  studies 
investigated the methylation status of individual loci; the 
first  [77]  showed  a  shift  towards  hypomethylation  and 
the other [39] to hypermethylation, indicating that there 
are locus­specific responses to the teratogenic effects of 
alcohol. Other studies have examined the post­implan­
tation effects of alcohol teratogenesis during a period of 
rapid  cell  growth  and  differentiation,  when  one  would 
expect  extreme  sensitivity  to  environmental  insults,  as 
reported in many studies (reviewed in [57]).
The  first  study  to  show  a  direct  epigenetic  effect  of 
alcohol exposure in the fetus was by Garro et al. [47], in 
which  the  authors  demonstrated  reduced  methylase 
activity and hypomethylation of fetal DNA. A later study 
[78]  showed  CpG  hypomethylation  associated  with 
upregulation of NMDA receptor 2B (NR2B) gene expres­
sion  in  mouse  fetal  cortical  neurons  following  chronic 
ethanol treatment. Many studies have demonstrated that 
maternal ethanol consumption during fetal development 
affects mouse and rat offspring, as reflected in phenotypic 
characteristics such as stunted growth and craniofacial 
anomalies  analogous  to  the  FASD  clinical  features. 
Exposure of mouse embryo cell cultures undergoing early 
neurulation (during the period of gastrulation) demon­
strated  DNA  methylation  mediated  alterations  in  gene 
expression that are proposed to contribute to the FASD 
phenotype [38].
Transgenerational  effects  of  alcohol  (as  well  as  of 
nutritional supplements and endocrine disrupters) must, 
of necessity, be mediated through the process of gameto­
genesis  and  can  be  modulated  by  the  maternal 
environment during pregnancy. There is little evidence to 
explain the mechanisms involved, but the consequences 
are beginning to be documented. Studies from a region in 
northern  Sweden,  using  meticulous  birth,  medical, 
lifestyle  and  mortality  records  and  meteorological  and 
agricultural  records  reflecting  food  availability,  have 
demonstrated significant correlations between environ­
mental  exposures  at  critical  periods  and  cross­genera­
tional outcomes [79,80]. These have been attributed in 
part  to  transgenerational  epigenetic  effects.  Nutrition 
supplementation  in  pregnant  mice  is  known  to  shift 
mouse coat color towards transcriptional silencing of the 
Avy  allele,  mediated  through  DNA  methylation,  as 
reflected by an increase in the proportion of pseudoagouti 
offspring [81,82]. In a rat model, exposure of pregnant 
dams  to  vinclozolin  and  methoxychlor  (endocrine 
disruptors)  during  the  period  of  gonadal  sex  differen­
tiation  in  the  fetus  led  to  decreased  spermatogenic 
capacity  in  the  male  offspring  and  an  increased 
susceptibility  to  adult­onset  diseases  and  hypercholes­
terol  emia in the F1 to F4 generations [83,84]. Given that 
the phenotypic effects of the gestational environmental 
interventions (nutritional supplementation and exposure 
to  endocrine  disruptors)  were  shown  to  persist  into 
unexposed  subsequent  generations,  this  could  be 
mediated through epigenetic mechanisms.
Further indirect evidence for transgenerational effects, 
which could lead to an increased prevalence of FASD in 
communities, come from behavioral and epidemiological 
studies.  Behavioral  studies  in  humans,  rats  and  mice 
suggest  that  in  utero  alcohol  exposure  may  confer 
increased  vulnerability  to  substance  misuse  (including 
alcohol  misuse)  or  addiction  in  young  offspring  and 
adolescents,  which  sometimes  persists  into  adulthood 
[85­90].  Studies  in  South  Africa  have  documented  a 
signifi  cant  increase  in  FAS  prevalence  in  a  specific 
community studied at two different times, though not a 
generation apart. A minimal prevalence of 40.5 per 1,000 
was reported in 2000, rising to 65.2 in a report from 2005, 
using the same diagnostic criteria [48,91].
The  studies  presented  in  this  section  are  consistent 
with  the  transmission  of  environmentally  acquired 
changes  in  epigenetic  status,  which  persist  to  variable 
extents in subsequent generations and depend on both 
the  stochastic  deposition  of  epigenetic  marks  during 
develop  ment and a changing environment.
Implications for prevention and treatment
FASD results in lifelong disability and there is no cure. 
The complex molecular basis leading to the development 
of FASD and the mechanisms that induce the teratogenic 
effects  remain  poorly  understood.  There  is  compelling 
evidence that, in addition to the environmental trigger, 
genetic  variation  and  epigenetic  remodeling  are 
important risk factors (Figure 1). There is no safe alcohol 
dose during pregnancy and, because susceptible genomic 
attributes in the mothers and their fetuses remain poorly 
understood,  there  is  no  sliding  scale  that  can  be 
administered to reassure pregnant women of their risks. 
It remains unclear to what extent the damage that occurs 
during fetal development and growth can be ameliorated 
through the process of early detection and educational, 
nutritional  and  physiological  intervention,  as  has  been 
suggested  in  some  studies  [2,92,93].  The  burden  of 
disease,  the  high  prevalence  of  FASD  and  the 
vulnerability  of  affected  individuals  has  led  to  the 
introduction of protective legislative guidelines in North 
American  countries,  but  not  yet  in  other  parts  of  the 
world [94,95].
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prevention strategies not only need to target the pregnant 
mother, but also need to focus on preconception alcohol 
use  in  both  parents  as  well  as  attitudes  surrounding  a 
culture  of  drinking.  To  develop  effective  prevention 
strategies  it  is  important  to  understand  the  molecular 
processes  underlying  FASD  and  the  physiological  and 
social  consequences  that  lead  to  excessive  alcohol  con­
sump  tion  before  and  after  conception.  Preventative 
strategies for FASD will therefore need to include a long­
term program, emphasizing abstention during the pre  con­
ception period as well as during pregnancy, with an under­
standing that immediate benefits are likely to be subtle but 
will accrue over subsequent generations. However, in the 
absence of effective preventative strategies the prevalence 
of  FASD  would  increase  and  the  burden  of  disease  in 
future generations would be magnified accordingly.
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Figure 1. In communities where alcohol abuse is common there is a high risk for FASD. This risk and the severity of the outcome depend 
on specific environmental triggers, genetic variation in the parents and the resulting combination in the fetus, and several critical time periods 
for epigenetic remodeling in a vulnerable fetus. The figure illustrates the complex interactions that affect the risk for developing a FASD/FAS 
phenotype. In the mother, alcohol metabolism and enzymes involved in epigenetic remodeling may be particularly important, as well as alcohol 
metabolism by the placenta and fetus. In the fetus, genes involved in alcohol metabolism, epigenetic remodeling and development, particularly in 
the central nervous system and brain, are probably important.
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